GYPON 2024
GYPON – 2de Highlight-Meeting Gynaecologie-Oncologie – Donderdag 28 november 2024 aanvang 18:30 Locatie: De RodeBol – Gent Voor meer informatie …
23rd Annual BSMO meeting 2021 will be held in full digital setting Saturday 6 February 2021
08:55 | Welcome and introduction – Sylvie Rottey, UZ Gent |
09:00 | Lecture renal cell carcinoma – chair Sylvie Rottey, UZ Gent Systemic treatment of RCC – Viktor Grünwald, University hospital Essen, Germany |
09:35 | Best of abstracts – chair Hans Prenen,UZA Antwerpen |
09:35 |
Introduction & explanation voting Best Junior Abstracts |
09:45 | Cardiotoxicity of immune checkpoint inhibitors (ICI): a systematic review and meta-analysis of randomized clinical trials – Elisa Agostinetto, Institut Jules Bordet |
09:55 | Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer – Hannah Van Belle, KU Leuven |
10:05 | Overall survival improvement in metastatic clear-cell renal cell carcinoma patients from 2000 to 2020 – Sofie Demasure, UZ Leuven |
10:15 | Cyclin dependent kinase inhibitors (CDK4-6i) as adjuvant treatment for patients (pts) with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (EBC): a systematic review and meta-analysis – Rafael Caparica, Institut Jules Bordet |
10:25 | Colchicine as salvage for refractory pyrexia due to BRAF and MEK inhibitors: a case report –Michael Saerens, UZ Gent |
10:35 | Break |
10:55 | Round table discussion rectal cancer – chair Joelle Collignon, CHU de Liège The changing landscape of neoadjuvant therapy in rectal cancer – Jeroen Dekervel, UZ Leuven Followed by a 15 min discussion with J. Collignon (CHU de Liège), J. Dekervel (UZ Leuven), Willem Lybaert (AZ Nikolaas) and Ines Joye (Iridium) |
11:30 | Round table discussion breast cancer – chair Evandro de Azambuja, Institut Jules Bordet |
11:31 | Escalation and de-escalation strategies in early breast cancer – Donatienne Taylor, St Elisabeth, Namur |
11:43 | New insights in the treatment of advanced triple-negative breast cancer –Kevin Punie, UZ Leuven Followed by a 15 min discussion with E. de Azambuja (Institut Jules Bordet), D. Taylor (St Elisabeth Namur) and K. Punie (UZ Leuven) |
12:10 | Keynote lecture – chair Kevin Punie, UZ Leuven Hereditary Cancer Syndromes: What the oncologist should know – Robin De Putter, UZ Gent |
12.30 | Break |
12:50 | Pfizer Award – chair Sylvie Rottey, UZ Gent The development, implementation and evaluation of an AYA-MOC in Belgium – Nathalie Belpame, UZ Gent (MP4) |
13:00 | BSMO Projects – chair Joelle Collignon, CHU de Liège |
13:00 | COVID-19 in hospitalized patients with solid cancer in Belgium: The BSMO COVID project – Mariana Brandao, Institut Jules Bordet |
13:10 | BSMO project – Immunomanager v 2.0: National multidisciplinary immunotox board – Sandrine Aspeslagh, UZ Brussel |
13:20 | Best Junior abstracts ceremony and closing remarks – Joelle Collignon, CHU de Liège & Sylvie Rottey, UZ Gent |
13:45 | Virtual general assembly – for BSMO members only |
Click here to download the final programme (PDF)
Accreditation with RIZIV/INAMI is pending
Registration is closed
Target audience: Medical oncologists and oncologists in training.
Other physicians with focus on cancer management are also welcome to join.
Call for original science abstracts
Abstract submission is now closed. Authors that have successfully submitted an abstract for our meeting will receive a notification about the review result in the week of 25 January 2021.
Let’s stay virtually connected, until we can meet again.
For more information about the meeting, please contact
Mieke Akkers – M+
meeting@bsmo.be
Tel +32 (0)486 888 888
GYPON – 2de Highlight-Meeting Gynaecologie-Oncologie – Donderdag 28 november 2024 aanvang 18:30 Locatie: De RodeBol – Gent Voor meer informatie …
18th Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice and Post-MASCC 29 & 30 November …
the 27th Annual BSMO meeting 2025 will take place in Bruges on Friday 31 January and Saturday 1 February 2025 …